We are live on ! Find out more

500 hedge funds and large institutions have $16.5B invested in Incyte in 2018 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 208 increasing their positions, 161 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 208 | Existing positions reduced: 161

0% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 65

0.41% less ownership

Funds ownership: 93.84%93.44% (-0.41%)

1% less funds holding

Funds holding: 503500 (-3)

3% less call options, than puts

Call options by funds: $438M | Put options by funds: $453M

12% less capital invested

Capital invested by funds: $18.8B → $16.5B (-$2.27B)

50% less funds holding in top 10

Funds holding in top 10: 126 (-6)

Holders
500
Holders Change
-3
Holders Change %
-0.6%
% of All Funds
11.43%
Holding in Top 10
6
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-50%
% of All Funds
0.14%
New
65
Increased
208
Reduced
161
Closed
65
Calls
$438M
Puts
$453M
Net Calls
-$14.4M
Net Calls Change
+$88.2M

INCY Hedge Fund Activity: Q1 2018 in Review

500 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q1 2018, worth a combined $16.5B — down 12% from $18.8B a quarter earlier.

Fund positioning in INCY was balanced in Q1 2018: 65 funds opened new positions, 65 closed out, 208 added to existing stakes and 161 trimmed.

The largest buyer was Sands Capital Management, adding an estimated $142M. The largest seller was HealthCor Management, cutting an estimated $110M.

  • 500 institutional investors held Incyte (INCY) as of Q1 2018, down from 503 in Q4 2017.
  • Funds reported $16.5B of Incyte stock for Q1 2018, down 12% quarter-over-quarter.
  • 65 funds opened new Incyte positions in Q1 2018 and 65 closed out, a net change of 0 holders.
  • The largest Incyte buyer in Q1 2018 was Sands Capital Management, an estimated $142M added.
  • The largest Incyte seller in Q1 2018 was HealthCor Management, an estimated $110M sold.

Based on aggregated 13F filings for Q1 2018.